Biotechnology Letters

Secondcell Bio Publishes Biotechnology for Improved Drug Discovery Originating from The Rockefeller University

Retrieved on: 
Wednesday, September 15, 2021

"Little more than a random and highly inefficient enterprise, drug discovery today is "garbage in, garbage out" enterprise.

Key Points: 
  • "Little more than a random and highly inefficient enterprise, drug discovery today is "garbage in, garbage out" enterprise.
  • Currently, the industry average failure rate for drug discovery programs in pharmaceutical companies is reported to be approximately 98%.
  • This work was performed by Chromocell Corporation, a biotechnology company spun out of The Rockefeller University based upon the technology.
  • Secondcell, Secondcell Bio, Cellbrary, Cellbraries, Chromo-Plasmid, pChromo-Plasmid, Chromo-Tag, Drugomics, Drug Discovery at Scale, and the Secondcell Bio logo are trademarks of Secondcell Bio, LLC.